China regulators offer VIP treatment for 48 overseas drugs they're ready to hustle up with accelerated reviews
China wants novel drugs already approved overseas to be available in the country faster. And in case some drugmakers didn’t get the memo, it’s now …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
